Komori
Muromachi Chemicals (4885) · FactAdvanced

Results for the nine months ended in the third quarter

First written in FY2021-Q3. 22 of 23 entries say "Advanced", first in FY2021. Latest entry: 2026-10-15.

23entries
6years
7from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021 – 2026-10-152021: 320212022: 420222023: 420232024: 220242025: 120252026: 92026
Same theme, other companies
Coexistence of Revenue and Profit Growth with a Decline in Net Income Attributable to Owners of the ParentA theme 122 companies write about · 24 as a headwind · 16 as a tailwind

25 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 122 companies compared. The sentences above are computed from all 122.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「As a result, for the fiscal year under review, net sales increased by ¥1,187.902 million, or 17.9%, year on year to ¥7,840.931 million, operating profit increased by ¥310.741 million, or 71.9%, to ¥742.930 million, and ordinary profit increased by ¥277.342 million, or 64.5%, to ¥707.436 million, while net income decreased by ¥78.250 million, or 32.4%, to ¥163.027 million.」

    Full-year results were updated. Net sales, operating income and ordinary income increased, while net income declined due to the recognition of an impairment loss.
  2. FY2026-H1AdvancedAnnual report

    「As a result, for the interim accounting period under review, net sales were ¥3,681.857 million, an increase of ¥716.827 million, or 24.2%, compared with the previous interim accounting period; operating income was ¥349.419 million, an increase of ¥194.933 million, or 126.2%; ordinary income was ¥336.660 million, an increase of ¥165.542 million, or 96.7%; and interim net income was ¥244.013 million, an increase of ¥123.307 million, or 102.2%.」

    During the interim accounting period under review, net sales, operating income, ordinary income and interim net income all increased year on year, with operating income rising particularly strongly, by 126.2%.
  3. FY2025-H1AdvancedAnnual report

    「As a result, for the interim accounting period under review, net sales were ¥2,965.030 million, an increase of ¥52.705 million, or 1.8%, compared with the previous interim accounting period; operating income was ¥154.486 million, an increase of ¥39.170 million, or 34.0%; ordinary income was ¥171.117 million, an increase of ¥61.030 million, or 55.4%; and interim net income was ¥120.705 million, an increase of ¥27.471 million, or 29.5%.」

    Results through the middle of the fiscal year were updated, presenting year-on-year increases in net sales, operating income, ordinary income and interim net income for the interim accounting period under review.
  4. FY2024-Q3AdvancedAnnual report

    「As a result, for the cumulative third quarter under review, net sales were ¥4,455.013 million, a decrease of ¥169.593 million, or 3.7%, year on year; operating income was ¥252.388 million, a decrease of ¥73.020 million, or 22.4%; ordinary income was ¥245.988 million, a decrease of ¥62.587 million, or 20.3%; and quarterly net income was ¥190.563 million, a decrease of ¥39.612 million, or 17.2%.」

    The results for the cumulative third quarter were updated, and net sales, operating income, ordinary income and quarterly net income all declined year on year.
  5. FY2024-Q2AdvancedAnnual report

    「As a result, for the cumulative second quarter under review, net sales were ¥2,912.325 million, a decrease of ¥208.920 million, or 6.7%, year on year; operating income was ¥115.315 million, a decrease of ¥110.094 million, or 48.8%; ordinary income was ¥110.087 million, a decrease of ¥97.824 million, or 47.1%; and quarterly net income was ¥93.234 million, a decrease of ¥56.056 million, or 37.5%.」

    The results for the cumulative second quarter were updated, and net sales, operating income, ordinary income and quarterly net income all declined year on year.
  6. FY2024-Q1AdvancedAnnual report

    「As a result, for the cumulative first quarter under review, net sales were ¥1,516.540 million, a decrease of ¥9.926 million, or 0.7%, year on year; operating income was ¥46.023 million, a decrease of ¥83.902 million, or 64.6%; ordinary income was ¥44.705 million, a decrease of ¥73.742 million, or 62.3%; and quarterly net income was ¥22.666 million, a decrease of ¥63.687 million, or 73.8%.」

    FY2024-Q1 results are presented. Net sales declined slightly, while operating income, ordinary income and quarterly net income fell sharply year on year.
  7. FY2023AdvancedAnnual report

    「As a result, for the fiscal year under review, net sales were ¥6,291.379 million, an increase of ¥610.279 million, or 10.7%, year on year; operating income was ¥369.413 million, a decrease of ¥67.928 million, or 15.5%; ordinary income was ¥350.890 million, a decrease of ¥72.151 million, or 17.1%; and net income was ¥256.302 million, a decrease of ¥199.970 million, or 43.8%.」

    Full-year results for the fiscal year ended May 2023 are presented. Net sales increased, while operating income, ordinary income and net income declined year on year.
  8. FY2023-Q3AdvancedAnnual report

    「As a result, for the cumulative third quarter under review, net sales were ¥4,624.606 million, an increase of ¥536.862 million, or 13.1%, year on year; operating income was ¥325.409 million, a decrease of ¥29.361 million, or 8.3%; ordinary income was ¥308.576 million, a decrease of ¥46.163 million, or 13.0%; and quarterly net income was ¥230.175 million, a decrease of ¥69.561 million, or 23.2%.」

    The results for the cumulative third quarter were updated. Net sales increased, while operating income, ordinary income and quarterly net income declined year on year.
  9. FY2023-Q2AdvancedAnnual report

    「As a result, for the cumulative second quarter under review, net sales were ¥3,121.245 million, an increase of ¥313.297 million, or 11.2%, year on year; operating income was ¥225.409 million, a decrease of ¥97.846 million, or 30.3%; ordinary income was ¥207.911 million, a decrease of ¥115.752 million, or 35.8%; and quarterly net income was ¥149.290 million, a decrease of ¥112.615 million, or 43.0%.」

    The results for the cumulative second quarter were updated. Net sales increased, while operating income, ordinary income and quarterly net income declined year on year.
  10. FY2023-Q1AdvancedAnnual report

    「As a result, for the cumulative first quarter under review, net sales were ¥1,526.467 million, an increase of ¥198.222 million, or 14.9%, year on year; operating income was ¥129.926 million, a decrease of ¥39.411 million, or 23.3%; ordinary income was ¥118.448 million, a decrease of ¥51.956 million, or 30.5%; and quarterly net income was ¥86.354 million, a decrease of ¥35.957 million, or 29.4%.」

    FY2023-Q1 results are presented. Net sales increased, while each profit measure declined year on year.
  11. FY2022AdvancedAnnual report

    「As a result, for the fiscal year under review, net sales were ¥5,681.099 million, an increase of ¥738.135 million, or 14.9%, year on year; operating income was ¥437.341 million, an increase of ¥68.005 million, or 18.4%; and ordinary income was ¥423.041 million, an increase of ¥83.719 million, or 24.7%. In addition, following a review of the Company's classification for the recoverability of deferred tax assets, net income was ¥456.272 million, an increase of ¥275.558 million, or 152.5%, year on year.」

    Year-on-year increases in net sales, operating income, ordinary income and net income are presented for the full fiscal year.
  12. FY2022-Q3AdvancedAnnual report

    「As a result, for the cumulative third quarter under review, net sales were ¥4,087.743 million, an increase of ¥400.467 million, or 10.9%, year on year; operating income was ¥354.771 million, an increase of ¥26.631 million, or 8.1%; ordinary income was ¥354.739 million, an increase of ¥51.561 million, or 17.0%; and quarterly net income was ¥299.737 million, an increase of ¥181.569 million, or 153.7%.」

    Year-on-year increases in net sales, operating income, ordinary income and quarterly net income are presented for the cumulative third quarter.
  13. FY2022-Q2AdvancedAnnual report

    「As a result, for the cumulative second quarter under review, net sales were ¥2,807.947 million, an increase of ¥325.212 million, or 13.1%, year on year; operating income was ¥323.255 million, an increase of ¥79.638 million, or 32.7%; ordinary income was ¥323.663 million, an increase of ¥104.113 million, or 47.4%; and quarterly net income was ¥261.906 million, an increase of ¥186.256 million, or 246.2%.」

    Results through the middle of the fiscal year are presented for net sales, operating income, ordinary income and quarterly net income for the cumulative second quarter, including year-on-year increases in both sales and income.
  14. FY2022-Q1AdvancedAnnual report

    「As a result, for the cumulative first quarter under review, net sales were ¥1,328.244 million, operating income was ¥169.338 million, ordinary income was ¥170.404 million and quarterly net income was ¥122.312 million.」

    New results for net sales, operating income, ordinary income and quarterly net income for the cumulative first quarter are presented.
  15. FY2021AdvancedAnnual report

    「As a result, for the fiscal year under review, net sales were ¥4,942.963 million, down 6.4% year on year; operating income was ¥369.336 million, up 22.7%; ordinary income was ¥339.322 million, up 21.9%; and net income was ¥180.714 million, up 425.5%.」

    The results were updated from the cumulative third quarter to the full fiscal year, presenting full-year results for net sales, operating income, ordinary income and net income.
  16. FY2021-Q3First statedAnnual report

    「As a result, for the cumulative third quarter under review, net sales were ¥3,687.275 million, operating income was ¥328.140 million, ordinary income was ¥303.178 million and quarterly net income was ¥118.167 million.」

    The results for the period from 1 June 2020 to 28 February 2021 are presented.
Moved together

"Steady sales of core pharmaceuticals and related products" moved the same way as this thread, in the same document, in 17 of its 23 moves.

17161513119★123456
  1. ★This thread
  2. 1Steady sales of core pharmaceuticals and related products17×
  3. 2Revenue Recognition from Large-Scale Equipment Projects and Solid Sales of Chemical Products16×
  4. 3Increase in Net Assets and Higher Equity Ratio15×
  5. 4Decline in sales and operating loss in the health foods business13×
  6. 5Operating Cash Flow Turning Negative and Decline in Cash Balances11×
  7. 6Executive Compensation Policy Including Restricted Stock9×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Muromachi Chemicals yet. It last moved in the Results briefing materials of 2026-10-15: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Results for the nine months ended in the third quarter | MUROMACHI CHEMICALS INC. (4885) | Komori